DBV Technologies S.A. American Depositary Shares (DBVT) Stock Price, Quote & AI Analysis

Live DBVT stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for DBV Technologies S.A. American Depositary Shares.

TradeVae provides AI-driven analysis and real-time market intelligence for DBV Technologies S.A. American Depositary Shares (DBVT), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.

D
DBVT
DBV Technologies S.A. American Depositary Shares
real-time
$0.00 +0.00 (+0.00%)
Open
11.750000
High
11.930000
Low
11.450000
Volume
145,987
VWAP
-
Market Cap
$746,547,599.16
52W Range
$8.63 - $26.19
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

DBV Technologies S.A. American Depositary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

DBV Technologies S.A. American Depositary Shares Overview

Company information

Company Overview

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Chatillon, France.

Company Details
Market Cap
$742.15M
Shares Outstanding
62,840,746
Weighted Shares Outstanding
62,840,707
CEO
Daniel Tassé
Address
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Employees
179
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and indicators

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

DBV Technologies S.A. American Depositary Shares Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...